Malaria drug study aims to save more Children's lives
NCT ID NCT05750459
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 27 times
Summary
This study looked at how the body processes IV artesunate in children with severe malaria. About 90 Ugandan children aged 6 months to 14 years received standard doses of the drug. Researchers measured changes in vital signs and lab values to better understand how the drug works and how to use it most effectively.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PLASMODIUM FALCIPARUM INFECTION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Makerere University-Infectious Diseases Institute
Kampala, Uganda
Conditions
Explore the condition pages connected to this study.